section name header

Pronunciation ⬇

DAS-i-GLOO-ka-gon

Classifications ⬆ ⬇

Therapeutic Classification: hormones

Pharmacologic Classification: pancreatics

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Stimulates glucagon receptors in liver, which stimulates the breakdown of glycogen and release of glucose from the liver.
Therapeutic effects:
  • Increase in blood glucose.

Pharmacokinetics ⬆ ⬇

Absorption: Unknown.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: Excreted through proteolytic degradation pathways in blood, liver, and kidney.

Half-Life: 30 min.

Time/Action Profile ⬆ ⬇

(increase in blood glucose concentrations)

ROUTEONSETPEAKDURATION
SUBQ10 min60 minUnknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Zegalogue